Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Shares of Humana Inc. HUM, -0.64% were indicated up fractionally in premarket trading Wednesday, after the health insurer reported third-quarter profit that beat expectations while sales came up a touch shy, and affirmed its full-year outlook. Net income fell to $1.30 billion, or $9.39 a share, from $1.64 billion, or $11.84 a share, in the year-ago period.

Humana beats profit expectations and affirms 2022 outlook, but revenue comes up a touch shy

Humana Reports Third Quarter 2022 Financial Results; Affirms Recent Upward Revision to Full Year 2022 Adjusted EPS Financial Guidance

Humana has an impressive earnings track record, exceeding the Zacks Consensus EPS Estimate in each quarter dating all the way back to 2016.

Humana Q3 Preview: Can The Earnings Streak Continue?

Humana's (HUM) Q3 results are expected to reflect growing premiums, attributable to its Medicare Advantage and Medicaid businesses. However, elevated marketing costs might have strained its margins.

Can Humana (HUM) Sustain Its Earnings Beat Streak in Q3?

“Healthcare” has done well this year in an otherwise down market and it still has opportunities that are worth buying, says Gina Sanchez – Chief Market Strategist at Lido Advisors.

Sanchez: this healthcare stock at an all-time high is still worth owning

Humana, Monogram Health Announce New Agreement that Enhances In-home Kidney Care in Four States

Elevance Health Inc

McKesson

All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.

3 Top-Ranked Medical Stocks Lapping the S&P 500

MEDNAX

Teladoc

Recovering volumes, improved admissions, growing health awareness and wide utilization of technologies in the third quarter are expected to have aided healthcare stocks like Humana (HUM), Teladoc (TDOC) and Pediatrix Medical (MD).

3 Healthcare Stocks Set to Outshine Q3 Earnings Estimates

Humana expands Medicare Advantage health plan offerings into Rhode Island, Wyoming and 140 new counties nationwide in 2023

Technology will bundle and accelerate prior authorization for cardiovascular and surgical services BOSTON , Oct. 24, 2022 /PRNewswire/ -- Today Cohere Health, a leader in intelligent utilization management (UM) technology, announced that Humana Inc.  (NYSE: HUM) will expand its use of Cohere's digital UM collaboration platform to enable seamless prior authorization for cardiovascular and surgical services. In addition to digitizing prior authorization requests for these services, the technology automates clinical intelligence into the provider's workflow, enabling episode-based, longitudinal management of the patient's care journey to reduce care variation, drive higher quality care, and minimize administrative burden.

Cohere Health and Humana Expand Partnership to Further Improve Physician and Member Experiences

CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits

Humana Announces Major Expansion of Florida Dental Network, Benefits

Humana (HUM) ties up with USAA Life to develop a Medicare Advantage plan that transcends the VA system to fetch added healthcare benefits for veterans.

Humana (HUM) Brings Affordable MA Plan to U.S. Veterans

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans' Needs

American Express

Kroger

The Fed's ongoing tightening cycle, paired with geopolitical uncertainties and lingering COVID-19 restrictions, has caused many stocks to pull back significantly in 2022. However, blue-chip stocks weather a dark fiscal cloud better than most.

3 Blue-Chip Stocks to Boost Your Portfolio's Defense

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Foundation invests $13 Million in health equity innovation and creating healthy emotional connections for vulnerable populations

Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, has announced that its Kentucky HMO plan has received the highest possible quality rating for the 2023 plan year from the Centers for Medicare and Medicaid Services (CMS). The Humana Health Plan of Ohio, Inc., an HMO plan offered in Boone, Campbell, Grant, Kenton and Pendleton counties in Kentucky, is one of three of Humana's Medicare Advantage plans in the nation that receive

For Second Time, Humana Kentucky Medicare Advantage HMO Plan Achieves Prestigious 5-Star Rating

NASHVILLE, Tenn.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced that, for the second year in a row, and the third time overall, its statewide Humana HMO Medicare Advantage plan in Tennessee has achieved the highest possible 5-star rating from the Centers for Medicare & Medicaid Services (CMS). Humana's Cariten Health Plan Inc. in Tennessee, an HMO plan offered in all of Tennessee's 95 counties, is one of three Humana plans in the nation to re

For Third Time, Humana Tennessee Medicare Advantage HMO Attains Medicare's Highest Rating for 2023

NEW ORLEANS--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, has announced that its statewide Louisiana Medicare Advantage HMO plan has received a top 5-star rating from the Centers for Medicare and Medicaid Services (CMS) for a second consecutive year. The Humana Health Benefit Plan of Louisiana, Inc. HMO plan, which has nearly 196,000 members as of September, is one of three Humana plans in the nation that received a 5-star rating, reflec

Humana Louisiana Medicare Advantage Plan Receives Highest Possible Rating for Two Years in a Row

Apple

AbbVie

Bank of America

iShares Core Dividend Growth ETF

Johnson & Johnson

JPMorgan Chase & Co

Morgan Stanley

Microsoft

iShares Short Maturity Bond ETF

Pfizer

iShares 1-3 Year Treasury Bond ETF

Funds investing in short-term Treasury bonds may be the best ETFs for investors in today's seesawing markets. The post Short-Term Treasury Rates Boost Appeal Of Bond ETFs appeared first on Investor's Business Daily.

Short-Term Treasury Rates Boost Appeal Of Bond ETFs

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, announced today the Medicare Star Ratings for its Medicare Advantage plans, effective Jan. 1, 2023, from the Centers for Medicare and Medicaid Services (CMS). With 4.9 million of Humana's Medicare Advantage members enrolled in plans rated 4 stars and above, Humana's Star Ratings continue to reflect the company's strong focus on ensuring high quality of care, patient-centered c

96% of Humana's Medicare Advantage Members are in Contracts rated 4-Star or Above for 2023; 66% are in Contracts Rated 4.5-Star or Higher

Molina Healthcare

Healthcare stocks generally carry a defensive nature, helping to shield investors from the market's volatility. Demand for the services these companies provide won't be going anywhere anytime soon.

3 Top-Ranked Healthcare Stocks Thriving in 2022

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2022 (3Q22) on Wednesday, November 2, 2022, at 6:30 a.m. Eastern time. The company will host a conference call at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2022. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BIfba19ab3227f4204bc0eef4067de8954. Upon r

Humana Inc. to Release Third Quarter 2022 Results on November 2, 2022

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members.

News for Humana Stock (HUM)